To evaluate the impact of Sema3C on tumor-initiating ability in vivo, a limiting dilution assay was conducted by subcutaneously injecting 5 × 105, 5 × 104, and 5 × 103 HCC cells into nude mice. Here, SEMA3C is linked to hepatocellular carcinoma.